Practical Approaches to Cardiovascular Risk Reduction in the Era of PCSK9 Inhibitors

2.00 CME
2.00 ACPE
120 MINS
$0 FEE


Program Overview

On December 9, 2019 the National Lipid Association and the American College of Cardiology visited Oklahoma State University in Tulsa to present Practical Approaches to Cardiovascular Risk Reduction in the Era of PCSK9 Inhibitors. Watch the proceedings from this live event to hear from experts Dr. Salim Virani and Dr. Margo Minissian on data from cardiovascular outcomes trials and clinical implications you need to know, recommended methods to overcome barriers to access of PCSK9 inhibitors (including effective ways to engage your patients), and lifestyle and diet counseling tips. 

Activity Type

Internet Enduring Activity

Release Date: 1/3/2020
Expiration Date: 12/31/2020

Target Audience

This activity is designed to meet the needs of lipid specialists, internists, endocrinologists, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses and registered dietitians with an interest in lipid management.

Learning Objectives

At the Conclusion of this activity, participants should be able to:

  • Explain cardiovascular outcomes trial data and its clinical applicability.
  • Outline the appropriate methods required to seek and obtain approval for prescribing of PCSK9 inhibition therapies.
  • Recognize the importance of lifestyle modification in the reduction of cardiometabolic risk and encourage such changes in their patients.
  • Formulate tailored management plans for patients with elevated cholesterol and co-morbidities who are at risk for a first-time or recurrent coronary event.
  • Discuss strategies to improve the knowledge, skills or performance of the healthcare team.

Criteria For Success

Statements of credit will be awarded based on the participant’s participation in the activity and post-assessment with a score of 75% or greater and submission of the activity evaluation form. Partial credit may be awarded for ACPE credit. A statement of credit will be available upon completion of an online evaluation/claimed credit form.

For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be available at within 4 weeks.

For Dietitians: Upon completion of the activity evaluation form, dietitians may submit evaluations of the quality of activities/materials to CDR. Poor evaluations of activities/materials may trigger an audit of the activities/ materials by CDR.

Commerical Support

This educational activity is supported by an educational grant from Amgen.

Credit Designation

abimSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

CME credit provided by the National Lipid Association

ACCME Jointly accredited

In support of improving patient care, this activity has been planned and implemented by The National Lipid Association and the American College of Cardiology. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement 

The National Lipid Association designates this enduring internet activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity. 

Physician Assistants

NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.


The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 2.00 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL0002.


Universal Activity Number – JA0007192-0000-20-004-H01-P (Application)
This Activity has been approved for 2.00 contact hour(s) (.20 CEUs) of the Accreditation Council for Pharmacy Education.


The maximum number of hours awarded for this CE activity is 2.0 contact hours.

This continuing education activity offered 0.9 pharmacotherapy contact hours.


Margo B. Minissian, PhD, ACNP, FNLA, FAHA
Research Scientist
Clinical Lipid Specialist
Cardiology Nurse Practitioner
Barbra Streisand Women’s Heart Center at the Smidt Cedars-Sinai Heart Institute

Salim S Virani, MD, PhD, FACC, FAHA
Medicine - Cardiology
Baylor College of Medicine

Auxiliary Faculty

Kim Birtcher, M.S, PharmD, AACC, FNLA
Clinical Professor
University of Houston College of Pharmacy

Keith Ferdinand, MD, FACC, FAHA, FNLA
Professor of Medicine
Tulane University School of Medicine
Tulane Heart and Vascular Institute


Roda Plakogiannis, PharmD, BS, BCPS, CLS, FNLA

Disclosure of Unlabeled Use and Investigational Products

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclosure Declaration

It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. Planners, faculty, reviewers, and staff have disclosed any financial relationships with commercial interests as defined by the ACCME.


This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of content.


The National Lipid Association acknowledges that permissions have been obtained for use of all copyrighted materials, including graphs, tables, pictures, and charts printed in this activity syllabus. Permissions have also been obtained from identifiable patients in photographs and other images, consistent with the DHHS HIPAA regulations for individual privacy.

Faculty/Planner Financial Disclosures

Birtcher, Kim
Other: Jones & Bartlett Publishing (Section Editor)

Ferdinand, Keith
Consultant: Amgen, Boehringer Ingelheim, Novartis, Quantum Genomics, Sanofi

Minissian, Margo
Advisory Board: Amgen
Consultant: Amgen

Virani, Salim
Nothing to disclose.

Staff/Reviewer Disclosures

NLA staff has nothing to disclose. 

Halli Demeter, Susan
Nothing to disclose.

Hemphill, Linda
Consultant: Akcea
Contracted Research: IONIS/ Akcea, The Medicines Company, Regeneron

Marrs, Joel
Nothing to disclose.

Plakogiannis, Roda
Nothing to disclose.